These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35296132)

  • 1. High CD44 Immunoexpression Correlates with Poor Overall Survival: Assessing the Role of Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma Patients from the High-Risk Population of Pakistan.
    Adnan Y; Ali SMA; Farooqui HA; Kayani HA; Idrees R; Awan MS
    Int J Surg Oncol; 2022; 2022():9990489. PubMed ID: 35296132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SHH Expression Is Significantly Associated With Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma.
    Cierpikowski P; Lis-Nawara A; Bar J
    Anticancer Res; 2021 Nov; 41(11):5405-5413. PubMed ID: 34732409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Stem Cell Markers, CD44 and ALDH1, for Assessment of Cancer Risk in OPMDs and Lymph Node Metastasis in Oral Squamous Cell Carcinoma.
    Dhumal SN; Choudhari SK; Patankar S; Ghule SS; Jadhav YB; Masne S
    Head Neck Pathol; 2022 Jun; 16(2):453-465. PubMed ID: 34655409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma.
    Hou YC; Chao YJ; Tung HL; Wang HC; Shan YS
    Cancer; 2014 Sep; 120(17):2766-77. PubMed ID: 24839953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prognostic Role of Cancer Stem Cell Markers for Long-term Outcome After Resection of Colonic Liver Metastases.
    Spelt L; Sasor A; Ansari D; Hilmersson KS; Andersson R
    Anticancer Res; 2018 Jan; 38(1):313-320. PubMed ID: 29277789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer stem cell markers predict a poor prognosis in renal cell carcinoma: a meta-analysis.
    Cheng B; Yang G; Jiang R; Cheng Y; Yang H; Pei L; Qiu X
    Oncotarget; 2016 Oct; 7(40):65862-65875. PubMed ID: 27588469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data.
    Bahnassy AA; Fawzy M; El-Wakil M; Zekri AR; Abdel-Sayed A; Sheta M
    Transl Res; 2015 Mar; 165(3):396-406. PubMed ID: 25168019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer.
    Wakamatsu Y; Sakamoto N; Oo HZ; Naito Y; Uraoka N; Anami K; Sentani K; Oue N; Yasui W
    Pathol Int; 2012 Feb; 62(2):112-9. PubMed ID: 22243781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of CD44 expression in oral squamous cell carcinoma: A meta-analysis.
    Mirhashemi M; Sadeghi M; Ghazi N; Saghravanian N; Dehghani M; Aminian A
    Ann Diagn Pathol; 2023 Dec; 67():152213. PubMed ID: 37856951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical expression of CD44 in oral squamous cell carcinoma in relation to histomorphological parameters and clinicopathological factors.
    Boxberg M; Götz C; Haidari S; Dorfner C; Jesinghaus M; Drecoll E; Boskov M; Wolff KD; Weichert W; Haller B; Kolk A
    Histopathology; 2018 Oct; 73(4):559-572. PubMed ID: 29468726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cancer stem cell markers ALDH1, BCL11B, BMI-1, and CD44 in the prognosis of advanced HNSCC.
    Jakob M; Sharaf K; Schirmer M; Leu M; Küffer S; Bertlich M; Ihler F; Haubner F; Canis M; Kitz J
    Strahlenther Onkol; 2021 Mar; 197(3):231-245. PubMed ID: 32588101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44+ cancer cell-induced metastasis: A feasible neck metastasis model.
    Wu TF; Chen L; Bu LL; Gao J; Zhang WF; Jia J
    Eur J Pharm Sci; 2017 Apr; 101():243-250. PubMed ID: 28215944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas.
    Elkashty OA; Abu Elghanam G; Su X; Liu Y; Chauvin PJ; Tran SD
    Carcinogenesis; 2020 Jun; 41(4):458-466. PubMed ID: 31742606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of cancer stem cell marker expression in primary head and neck squamous cell carcinoma shows prognostic value for aldehyde dehydrogenase (ALDH1A1).
    Szafarowski T; Sierdziński J; Ludwig N; Głuszko A; Filipowska A; Szczepański MJ
    Eur J Pharmacol; 2020 Jan; 867():172837. PubMed ID: 31811857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic evaluation of tumour budding in oral squamous cell carcinoma: Evidenced by CD44 expression as a cancer stem cell marker.
    Niranjan KC; Raj M; Hallikeri K
    Pathol Res Pract; 2023 Nov; 251():154883. PubMed ID: 37898041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the potential cancer stem cell markers CD133 and CD44 in medullary thyroid carcinoma: A ten-year follow-up and prognostic analysis.
    Bi Y; Meng Y; Wu H; Cui Q; Luo Y; Xue X
    J Surg Oncol; 2016 Feb; 113(2):144-51. PubMed ID: 26799258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of stem cell biomarker CD44 in oral squamous cell carcinoma and its association with lymph node metastasis and TNM staging.
    Chakraborty S; Suresh TN; Azeem Mohiyuddin SM
    J Cancer Res Ther; 2024 Jul; 20(5):1430-1434. PubMed ID: 39412907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of p63 and CD44 in oral squamous cell carcinoma and correlation with clinicopathological parameters.
    Saghravanian N; Anvari K; Ghazi N; Memar B; Shahsavari M; Aghaee MA
    Arch Oral Biol; 2017 Oct; 82():160-165. PubMed ID: 28645102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44 and ALDH1 immunoexpression as prognostic indicators of invasion and metastasis in oral squamous cell carcinoma.
    Ortiz RC; Lopes NM; Amôr NG; Ponce JB; Schmerling CK; Lara VS; Moyses RA; Rodini CO
    J Oral Pathol Med; 2018 Sep; 47(8):740-747. PubMed ID: 29791975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSC
    Ortiz RC; Amôr NG; Saito LM; Santesso MR; Lopes NM; Buzo RF; Fonseca AC; Amaral-Silva GK; Moyses RA; Rodini CO
    Sci Rep; 2024 May; 14(1):10583. PubMed ID: 38719848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.